MedTrace Logo

Hemosonics- VCU Cardiac Surgery Clinical Study

NCT02392247 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 52

Last updated 2016-07-12

Study results available
· View outcomes & findings →

Summary

This study compares the results of current standard coagulation measurement devices to the Quantra System, a new device, using small amount of extra blood obtained during routine blood draws in cardiac surgery patients.

Conditions

  • Cardiopulmonary Bypass

Interventions

DEVICE

Coagulation function

Coagulation function assessment tools TEG (standard of practice) vs SEER Quantra (novel coagulation function device)

Sponsors & Collaborators

  • HemoSonics LLC

    collaborator INDUSTRY

  • Virginia Commonwealth University

    lead OTHER

Principal Investigators

  • Bruce Speiss, M.D. · Virginia Commonwealth University

Eligibility

Min Age
18 Years
Max Age
89 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2015-04-30
Primary Completion
2015-09-30
Completion
2015-09-30

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02392247 on ClinicalTrials.gov